Polaryx investors elect directors, ratify auditor
Polaryx Therapeutics stockholders elected two Class I directors through 2029 and ratified Grant Thornton LLP as auditor for fiscal 2026.
Rhea-AI Filing Summary
Polaryx Therapeutics, Inc. (PLYX) reported the results of its September 10, 2026 Annual Meeting of Stockholders. Stockholders elected Class I directors Alex Yang and Mitchel Berger to serve until the 2029 annual meeting, or until their successors are elected and qualified. Each director received 30,072,137 votes cast for, 332 votes withheld, and 472,610 broker non-votes. Stockholders also ratified the appointment of Grant Thornton LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, with 30,510,106 votes for, 34,973 against, and no abstentions and no broker non-votes for this proposal.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 5.07 — Submission of Matters to a Vote of Security Holders
1 item
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Key Figures
Votes for Alex Yang: 30,072,137 votes
Votes withheld for Alex Yang: 332 votes
Broker non-votes for director elections: 472,610 votes
+3 more
6 metrics
Votes for Alex Yang
30,072,137 votes
Election as Class I director at the September 10, 2026 annual meeting
Votes withheld for Alex Yang
332 votes
Election as Class I director at the September 10, 2026 annual meeting
Broker non-votes for director elections
472,610 votes
Election of each Class I director at the 2026 annual meeting
Votes for auditor ratification
30,510,106 votes
Ratification of Grant Thornton LLP for fiscal year ending December 31, 2026
Votes against auditor ratification
34,973 votes
Ratification of Grant Thornton LLP for fiscal year ending December 31, 2026
Abstentions on auditor ratification
0 votes
Ratification of Grant Thornton LLP for fiscal year ending December 31, 2026
Key Terms
Annual Meeting of Stockholders, Class I Directors, broker non-votes, Independent Registered Public Accounting Firm, +1 more
5 terms
Annual Meeting of Stockholders regulatory
"held its Annual Meeting of Stockholders on Thursday, September 10, 2026"
Class I Directors regulatory
"The following nominees for Class I Directors were elected"
Class I directors are the subset of a company’s board whose terms expire at a specific annual meeting under a staggered election system that divides directors into multiple groups with different re-election years. For investors this matters because staggered classes slow how quickly shareholders can replace the board, affecting takeover risk, governance change and the pace of corporate decisions — like rotating only part of a team instead of swapping everyone at once.
broker non-votes financial
"Broker Non-Votes Alex Yang ... 472,610"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
Independent Registered Public Accounting Firm regulatory
"as the Company’s Independent Registered Public Accounting Firm for the fiscal year"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
ratification regulatory
"The ratification of the appointment of Grant Thorton LLP"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did PLYX stockholders approve at the September 10, 2026 annual meeting?
Stockholders of Polaryx Therapeutics, Inc. (PLYX) elected Alex Yang and Mitchel Berger as Class I directors through 2029 and ratified Grant Thornton LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
How many votes did PLYX director nominees receive at the 2026 annual meeting?
Alex Yang and Mitchel Berger each received 30,072,137 votes for, with 332 votes withheld and 472,610 broker non-votes at the September 10, 2026 annual meeting of Polaryx Therapeutics, Inc.
Was the auditor ratification for PLYX approved and by what margin?
Yes. Ratification of Grant Thornton LLP as Polaryx Therapeutics’ independent registered public accounting firm for fiscal 2026 received 30,510,106 votes for, 34,973 votes against, and no abstentions, with no broker non-votes recorded for this proposal.
How long will the newly elected Class I directors of PLYX serve?
The Class I directors of Polaryx Therapeutics, Inc., Alex Yang and Mitchel Berger, will serve until the 2029 annual meeting of stockholders or until their respective successors are elected and qualified, as disclosed in the voting results.
On what date did PLYX hold its 2026 annual meeting of stockholders?
Polaryx Therapeutics, Inc. held its 2026 Annual Meeting of Stockholders on Thursday, September 10, 2026. The meeting covered director elections and ratification of the independent registered public accounting firm for the fiscal year ending December 31, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.
